Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT06289192Phase 4Completed
Phase 4, open-label, single-arm trial, sponsored by Johns Hopkins University. Primary endpoints: Acceptability and Feasibility as Assessed by the Number of Participants Who Complete Intervention and Surveys at 3 months and Acceptability and Feasibility as Assessed by Barriers to Screening at 3 months. Started Apr 2024; status: completed.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT06289192.